Dr. Shree Nath to participate in panel at DIA/FDA's Annual Meeting in Maryland on March 22nd-23rd

The FDA, in association with the Drug Information Association, has invited Dr. Shree Nath to participate on a panel at its annual CDER/CBER Computational Science Annual Meeting in Bethesda, Maryland on March 22nd-23rd.

Join us for our session on Tuesday March 23rd at 10:15am on Current Initiatives in Nonclinical, including SEND and ToxVision™.  This breakout group panel is chaired by members of the FDA, and includes representatives from Eli Lilly and the FDA.

This session will provide a current state of affairs for the review of pharmacology/toxicology information in support of premarket regulatory review of drugs and biologics. The session will provide a forum to share progress on ongoing initiatives including data standards development for animal toxicology data and tool development. The forum will be open to discuss steps forward to address the identified gaps in the current state and identify best practices for proposed tools and solutions.

Learn More

• Schedule a meeting with PointCross at DIA/FDA on March 22nd or 23rd
• Register for our webinar on Cross-Study Search & Meta-Analysis for Safety Data on March 31st
• See our Search & Safety Data Integration (SDIS™) solution in action
• Join us for our session on "Early Safety Assessments Through Semantically Relevant Search & Data Exchange" at ToxExpo March 8th-10th

Contact

For more information on SDIS™ and our other solutions for pharma, contact:
Dr. Shree Nath, VP of Pharmaceuticals
E-mail: Shree.Nath@pointcross.com
or call us at (650) 350-1900